Overview


Creative Medical Technology Holdings, Inc. (CELZ) is a biotechnology company committed to improving patient lives via a regenerative approach to immunology, endocrinology, urogynecology, and orthopedics.

Recent News
Nov 15, 2023
Creative Medical Technology Holdings Provides Corporate Update

Continuing to Advance Regenerative Therapies for Diabetes and Chronic Lower Back Pain Strong Financial Position with No Long-Term Debt PHOENIX, Nov. 15, 2023 /PRNewswire/ -- Creative Medical...

Oct 10, 2023
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

Company reaches next clinical trial milestone for the intramuscular treatment of Chronic Lower Back Pain with the first novel allogenic cellular therapy in the United States PHOENIX, Oct. 10, 2023...

Sep 19, 2023
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy,...

Events
American Urological Association
Friday, May 13, 2022 - Monday, May 16, 2022

Register

Stock Chart
NASDAQCELZ
Stock Info
NASDAQCELZ
NASDAQCELZ
IR Contact
The Equity Group Inc.
Devin Sullivan
Senior Vice President
dsullivan@equityny.com
(212) 836-9608

David Shayne
Analyst
dshayne@equityny.com
(212) 836-9628